Developing bioassay methods requires a new approach for cell and gene therapy drug development.
Catherine Liloia
Advertisement
Catherine Liloia, [email protected], is director at PPD Laboratories’ GMP cell lab.
Articles by Catherine Liloia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
2
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
3
USP Reports Drug Discontinuations on the Rise
4
Patient Access to Radiopharmaceuticals
5